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ABSTRACT 
The  objective  of necessary  work to develop Piroxicam  f a s t   dissolving tablets using  natural  disintegrants  which would release the  drug  rapidly with predetermined  rate. 
Six batches  of Piroxicam f a s t   dissolving tablets were prepared by using  natural and synthetic disintegrating agents in order to get required theoretical release profiles. The 
influence of  the  disintegrant concentration on the release of Piroxicam  was studied. The formulated batches were characterized by different physical parameters. The  study 
reveals  that the formulation prepared by direct compression F5 exhibits better dissolution, disintegration at low concentration of natural disintegrants. Physical parameters of 
all the formulated tablets were within the acceptable limits. 
Key words: Dispersible tablets, Crosscarmillose sodium, Natural disintegrants. Piroxicam. 
 
INTRODUCTION 
Fast  dissolving drug  delivery  is  rapidly  gaining acceptance  as  an 
important  new  drug  delivery  technology
1.  These  dosage  forms 
dissolve  or  disintegrate  within  few  minutes.  Usually, 
superdisintegrant are added to a drug formulation to facilitate the 
break up or disintegration of tablet content into smaller particles that 
can  dissolve  more  rapidly  than  in  the  absence  of 
disintegrants
2,3.Many  substances  like  microcrystalline  cellulose
4, 
crospovidone
5,  croscarmello  sodium
6,  1,  sodium  starch  glycolate
7, 
have been used in the formulation of fast dissolving tablets (FDT’s). 
Similarly,  various  natural  substances  like  gum  karaya,  modified 
starch  and  agar  have  been  used  in  the  formulation  of  FDT’s. 
Mucilage  of  natural  origin  is  preferred  over  semi‐synthetic  and 
synthetic  substances  because  they  are  comparatively  cheaper, 
abundantly available, non‐irritating and nontoxic in nature. 
Piroxicam is an effective non steroidal anti-inflamatory drug used 
for the treatment of rheumatoid arthritis and osteoarthritis 
8. The 
usual daily dose is 20 mg. Sometimes given in two doses, because 
of long period required to obtain steady state. Piroxicam is readily 
observed after oral or rectal administration and accumulation after 
repeated doses  to  reach  steady state after about 7 days. The drug 
is extensively metabolized to apparently in active metabolites and 
has a half  life of about 40 hrs. in man. Peak plasma concentrations 
are attained about  2 hrs after a single oral dose. Due to extended 
plasma half life of Piroxicam, plasma concentration  remain very 
stable over the next 24-48 hrs. Piroxicam is highly protein bound 
and thus might be expected to displace other protein bound drugs. 
Piroxicam is an effective anti-inflamatory agent, it is about equal in 
potency  to  indomethacin  as  an  inhibitor  of  prostaglandin 
biosynthesis, in vitro. 
Crosscarmillose and treated agar are used in present work. Agar is 
modified to treated agar by treating with water for one day.  
MATERIALS AND METHODS 
Piroxicam  was  obtained  from  Eros  Pharmaceuticals,  Bangalore. 
Lactose procured by New Modern Chemical. 
Preparation of treated agar 
Suaitable quantity of agar powder (5-10gm) weighed and added in 
distilled water(100 ml). agitation is continuously by strirrer for day 
to swell. The swollen contents were dried on a tray for three days at 
a room temperature. The dry powder were griended by pestle and 
mortar. Then griended powder was passed through sieve no. 100.
9 
Preparation  of Mixed Blend of Drug and Excipients 
All  the  ingredients  were  passed  through  mesh  no  60.  Required 
quantity  of  each  ingredient    was  taken  for  each  specified 
formulation (depicted in the Table-I) and all the ingredients   were  
subjected   to   grinding   to   a   required degree  of  fineness.  The 
powder  blend  was evaluated  for flow properties as follows. 
Angle of Repose 
Angle of  repose  was  determined  using  funnel  method
10 . The 
blend  was  poured  through  a funnel  that  can  be raised vertically 
until  a maximum  cone  height  (h) was obtained.  Radius   of  the  
heap    (r)  was    measured    and    the    angle    of  repose  (q)  was 
calculated using the formula. 
A n g l e   o f   r e p o s e    = Tan-1 (h/r) 
Bulk Density 
Apparent   bulk  density  (Pb)  was  determined   by  pouring the 
blend  into  a  graduated  cylinder
11.  The  bulk  volume  (V  )  and 
weight of the powder (M) was determined.  The bulk density was 
calculated using the formula. 
Pb = M/V 
Tapped Density 
The measuring cylinder  containing  a  known  mass  of blend was 
tapped for a fixed time. The minimum volume (Vt)  occupied  in the 
cylinder  and  the  weight  (M)  of  the blend   was   measured.   The 
tapped  density  (Pt  ) was calculated using the following formula, 
Pt = M/ Vt 
Compressibility  Index 
The   simplest   way   for   measurement   of   free   flow   of powder 
is  compressibility,    a  indication    of  the  ease  with  which    a  
material   can  be  induced   to  flow  is  given  by compressibility 
index (I)
12 which is calculated as follows, 
I= V0-Vt/Vbx 
Where,  V0  is  the  bulk  volume  and  Vt   is  tapped  volume. The  
value  below  15%  indicates  a  powder  with  usually give  rise  to  
good   flow   characteristics,   whereas   above 25%  indicate  poor 
flowability. 
Hausner ratio 
Hausner ratio
12 is an indirect index of ease of powder flow calculated 
by following formula, 
Hausner ratio = Pt /Pd 
Where Pt is tapped density and Pd is bulk density, Lower Hausner  
ratio  (<1.25)    indicates  better  flow  properties than higher ones 
(>1.25) 
EVALUATION  OF TABLETS 
Weight Variation 
Twenty tablets  were  selected  at  a  random  and  average weight Prakash Pawan et al. IRJP 2011, 2 (11), 159-162 
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was  determined.  Then  individual  tablets  were  weighed  and 
compared with average weight
13. 
Friability 
Friability  of  the  tablets
14  was  determined  using  Roche  friability  
(Electrolab,    Mumbai).    This  device  subjects  the  tablets  to  the 
combined  effect  of  abrasions  and  shock  in  a  plastic    chamber  
revolving  at  25  rpm  and  dropping  the tablets   at   a  height   of  
6   inches   in   each   revolution. Preweighed sample of tablets was 
placed  in the  friabilator  and  were  subjected  to  100  revolutions.  
Tablets  were  de dusted  using a soft muslin  cloth and reweighed. 
The friability (f) is given by the formula. 
f = (1- W0 / W) × 100 
Where,  W0 is weight  of the  tablets  before  the  test  and W is the 
weight of the tablet after the test. 
Hardness 
Hardness
15 or tablet  crushing   strength (F0)  (the   force required to 
break  a  tablet  in  a  diametric  compression)  was  measured  using 
Monsanto  tablet  hardness  tester  (Sheetal  Scientific  Industries, 
Mumbai) 
Drug Content 
Five  tablets  were  powdered and  the  blend  equivalent  to 10   mg  
of  piroxicam   was   weighed   and   dissolved   in suitable  quantity 
of  methanol.  The  solution  was  filtered, suitably  diluted  and the 
drug  content  was  analyzed  spectrophotometrically  at  362  nm
16. 
Each sample was analyzed in triplicate. 
Modified disintegration test 
For  measurement  of  disintegration  time,  a  petridish  (10  cm 
diameter) was filled with 10 ml of water. The tablet was carefully 
put in the center of petridish and the time for the tablet to completely 
disintegrate into fine particles was noted
17.  
Wetting time and water absorption ratio 
Wetting time is closely related to the inner structure of the tablets 
and hydrophilicity of the excipients. A piece of tissue paper, folded 
double, was placed in a Petri plate containing 6 ml of distilled water. 
A  preweighed  tablet  was  placed  on  the  paper  and  the  time  for 
complete wetting of the tablet was measured in seconds. The wetted 
tablet  was  then  weighed
18.Water  absorption  ratio  was  determined 
using the formula, 
R = (Wa-Wb)/Wa X 100 
 Where R = Water absorption ratio 
  Wa= Weight of tablet after wetting. 
  Wb= Weight of tablet before wetting. 
In- vitro dissolution test 
USP  dissolution  apparatus  1  and  2  can  be  used.  USP  1Basket 
apparatus  may  have  certain  applications,  but  sometimes  tablet 
fragments or disintegrated tablet masses may become trapped on the 
inside top of the basket at the spindle where little or no effective 
stirring occurs, yielding irreproducible dissolution profiles. Kancke 
proposed USP 2 Paddle apparatus, which is the most suitable and 
common choice for ODTs, with a paddle speed of 50 rpm commonly 
used. Typically, the dissolution of ODT is very fast when using USP 
monograph conditions; hence, slower paddle speeds may be utilized 
to  obtain  a  profile.  The  release  rate  piroxicam  from  orally 
disintegrating  tablets  was  determined  using  United  State 
Pharmacopoeia  (USP)  dissolution  testing  apparatus  II  (paddle 
method, Electrolab, TDT-06T, Mumbai, India). The dissolution test 
was performed using 900 ml of 0.1 N HCl (PH=1.2), at 37 ± 0.5°C 
and 50 rpm. A sample (10 ml) of the solution was withdrawn from 
the dissolution apparatus at 10, 20, 30, 40, 50, 60 and 70min. The 
samples  were  replaced  with  fresh  dissolution  mediumof  same 
quantity.  The  samples  were  filtered  through  a  0.45  μ  membrane 
filter. Absorbance of these solutions was measured at 333 nm using 
a  Shimadzu  UV-1700  UV/Vis  double  beam  spectrophotometer. 
Cumulative  percentage  of  drug  release  was  calculated  using  an 
equation obtained from a standard curve
19, 20. 
RESULTS AND DISCUSSION 
Six   formulations    of   Piroxicam   were   prepared   with varying 
concentration  of  super-disintegrants:  crosscramellose  sodium  and 
treated  agar.  Microcrystalline  cellulose  PH  102  was  used  as 
diluent.  For each  formulation,  blend  of drug and excipients  were 
prepared and evaluated for various parameters as  explained earlier.  
The  powder  blend  was  compressed  using  direct  compression   
technique.   Bulk density was  found  in  the range of 0.314  – 0.382 
g/cm
3 and  the  tapped  density  between 0.391  and  0.433-g/  cm
3 
table  II.  Using  these  two-density  data  Hausner’s  ratio  and 
compressibility index was calculated.  The powder blends of all the 
formulations had  Hausner’s  ratio  of  1.2  or  less  indicating  good 
flowability.    The  compressibility  index  was  found  between  12.8 
and  14.8  and  the  compressibility-flowability  correlation  data 
indicated  a fairly  good  flowability   of  the  powder  blend.  The 
good flowability  of  the  powder  blend  was  also  evidenced  with 
angle  of  repose  (range  of  27-30
0),  which  is  below  40
0indicating 
good flowability (Table-II). Tablets  were   prepared  using  direct 
compression  technique.    Since  the  powder  material  was  free 
flowing, tablets were obtained of uniform weight variations as per 
Pharmacopoeial   specifications.   The drug content   was found  in 
the  acceptable limit and the hardness  of the tablets  between  2.6 – 
3.2 kg/cm
2 Table II. Friability of the tablets were found below 1 % 
indicating    a   good   mechanical    resistance    of   tablets. The 
water  absorption  ratio  was  suffficient  to  all  preparation.  The 
corelation  between  water absorption ratio and disintegration time 
(DT) was found practically good for all formulations where F5 show 
good corelation (Figure 1). 
The in vivo disintegration time   (DT) of the tablets  was found   to   
be   less   than   60   sec. 
The  in  vitro  dissolution  profile  (Figure  2)  indicated  a  faster  and 
maximum of 99.3% drug release from formulation F5 proving the 
disintegrant property of treated agar gum (Table III). 
CONCLUSION 
From  all  the  above  observations  it  was  concluded  that  the 
formulation F5 containg d/p ratio1:0.6 Treated agar gum found to be 
better  formulation  in  terms  of  rapid  disintegration  and  maximum 
percentage drug release when compared with all other formulations.  
The drawbacks of the conventional dosage forms of Piroxicam can be 
minimized  by  Piroxicam  Fast  dispersible  tablets.  The  formulations 
prepared with superdisintegrant showed a rapid drug release and from 
the results of the above study clearly indicated that Piroxicam may be 
formulated  as  Fast  dispersible  tablets  using    superdisintegrants 
Crosscarmilose  sodium  and natural  superdisintegrants  Treated  agar 
gum. So natural superdisintegrant like treated agar exhibited faster 
drug  dissolution  will  lead  to  improve  bioavailability,  effective 
therapy, improve patient compliance, and satisfies all the criteria as 
fast dissolving tablet. 
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Table I  Formulation  of Piroxicam Fast dispersible  Tablets 
S.No  Composition  F1  F2  F3  F4  F5  F6 
1  Piroxicam  20  20  20  20  20  20 
2  Croscarmellose sodium  6  12  18  -  -  - 
3  Treated agar  -  -  -  6  12  18 
4  Microcrystalline cellulose  110  104  98  110  104  98 
5  Mannitol  54  54  54  54  54  54 
6  Aspartame   
8 
 
8 
 
8 
 
8 
 
8 
 
8 
7  Magnesium stearate  2  2  2  2  2  2 
8  Menthol  qs  qs  qs  qs  qs  qs 
  Total Weight (Mg)  200  200  200  200  200  200 
 
Table II Evalution  of Mixed  Powder  blend 
 
S.No 
Batch 
code 
Angle of repose(degrees)* 
Bulk density(gm/cm
3
)*  Tapped density(gm/cm
3
)* 
Compressibility 
index(%)* 
Hausner ratio* 
1  F1  28º.54 ±0.031  0.324±0.012  0.406± 0.015  14.42±0.054  1.15±0.058 
2  F2  29º.96±0.040  0.333±0.011  0.409±0.017  14.35±0.033  1.16±0.0624 
3  F3  30º.23±0.033  0.330±0.013  0.393±0.059  14.80±0.064  1.18±0.036 
4  F4  28º.92±0.021  0.382±0.015  0.433±0.075  14.69±0.064  1.16±0.038 
5  F5  27º.27±0.043  0.314±0.017  0.403±0.013  12.83±0.098  1.13±0.041 
6  F6  28º.31±0.026  0.314±0.031  0.391±0.028  13.74±0.064  1.14±0.065 
Table-III Evaluation of Fast dispersible  Tablet of Piroxicam 
S.No  Batch 
code 
Weight 
variation 
(mg)* 
Thickness* (mm)  Hardness* 
(kg/cm
2
) 
Friability (%) 
 
 
Drug Content 
(%)* 
Disintegration 
(sec)* 
Water absorption 
ratio% * 
1  F1  202±1.2  3.58±0.07  2.6±0.256  0.73±0.064  98.56±0.43  31±0.51  88.44±0.56 
2  F2  200±1.4  3.43±0.013  2.7±0.243  0.74±0.182  99.13±0.67  29±0.45  91.88±0.15 
3  F3  201±0.9  3.66±0.418  2.6±0.562  0.68±0.168  99.57±0.84  27±0.28  96.16±1.93 
4  F4  199±1.8  3.30±0.423  3.2±0.171  0.63±1.163  98.96±0.328  29±0.77  84.06±2.60. 
5  F5  201±1.2  3.69±0.273  3.1±0.370  0.44±0.482  99.37±0.240  21±0.53  85.87±4.66 
6  F6  199±1.3  3.51±0.348  2.9±0.231  0.39±0.663  99.26±0.472  16±0.43  88.25±6.45 
 
 
 
 
Figure 1 Comparison between Disintegration time and Wetting time Prakash Pawan et al. IRJP 2011, 2 (11), 159-162 
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                    Figure 2 %drug release with time 
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